Dipotassium;6-bromo-1-pyrimidin-2-ylpyrrolo[3,2-b]pyridine;6-bromo-1H-pyrrolo[3,2-b]pyridine;2-chloropyrimidine;[(4R)-4-[(4S)-5,5-dimethyl-2-oxo-4-phenyl-1,3-oxazolidin-3-yl]cyclohexen-1-yl] trifluoromethanesulfonate;(4S)-5,5-dimethyl-4-phenyl-3-[(1R)-4-(1-pyrimidin-2-ylpyrrolo[3,2-b]pyridin-6-yl)cyclohex-3-en-1-yl]-1,3-oxazolidin-2-one;tris((4S)-5,5-dimethyl-4-phenyl-3-[4-(1-pyrimidin-2-ylpyrrolo[3,2-b]pyridin-6-yl)cyclohexyl]-1,3-oxazolidin-2-one);hydride;oxido formate;bis(1-pyrimidin-2-yl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrrolo[3,2-b]pyridine)
C187H189B2Br2ClF3K2N37O20S — CID 162047905
Data last refreshed: (MolForge compound catalog, from PubChem)
About Dipotassium;6-bromo-1-pyrimidin-2-ylpyrrolo[3,2-b]pyridine;6-bromo-1H-pyrrolo[3,2-b]pyridine;2-chloropyrimidine;[(4R)-4-[(4S)-5,5-dimethyl-2-oxo-4-phenyl-1,3-oxazolidin-3-yl]cyclohexen-1-yl] trifluoromethanesulfonate;(4S)-5,5-dimethyl-4-phenyl-3-[(1R)-4-(1-pyrimidin-2-ylpyrrolo[3,2-b]pyridin-6-yl)cyclohex-3-en-1-yl]-1,3-oxazolidin-2-one;tris((4S)-5,5-dimethyl-4-phenyl-3-[4-(1-pyrimidin-2-ylpyrrolo[3,2-b]pyridin-6-yl)cyclohexyl]-1,3-oxazolidin-2-one);hydride;oxido formate;bis(1-pyrimidin-2-yl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrrolo[3,2-b]pyridine)
Dipotassium;6-bromo-1-pyrimidin-2-ylpyrrolo[3,2-b]pyridine;6-bromo-1H-pyrrolo[3,2-b]pyridine;2-chloropyrimidine;[(4R)-4-[(4S)-5,5-dimethyl-2-oxo-4-phenyl-1,3-oxazolidin-3-yl]cyclohexen-1-yl] trifluoromethanesulfonate;(4S)-5,5-dimethyl-4-phenyl-3-[(1R)-4-(1-pyrimidin-2-ylpyrrolo[3,2-b]pyridin-6-yl)cyclohex-3-en-1-yl]-1,3-oxazolidin-2-one;tris((4S)-5,5-dimethyl-4-phenyl-3-[4-(1-pyrimidin-2-ylpyrrolo[3,2-b]pyridin-6-yl)cyclohexyl]-1,3-oxazolidin-2-one);hydride;oxido formate;bis(1-pyrimidin-2-yl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrrolo[3,2-b]pyridine) (PubChem CID 162047905) has the molecular formula C187H189B2Br2ClF3K2N37O20S and a molecular weight of 3658.95 g/mol. Its IUPAC name is dipotassium;6-bromo-1-pyrimidin-2-ylpyrrolo[3,2-b]pyridine;6-bromo-1H-pyrrolo[3,2-b]pyridine;2-chloropyrimidine;[(4R)-4-[(4S)-5,5-dimethyl-2-oxo-4-phenyl-1,3-oxazolidin-3-yl]cyclohexen-1-yl] trifluoromethanesulfonate;(4S)-5,5-dimethyl-4-phenyl-3-[(1R)-4-(1-pyrimidin-2-ylpyrrolo[3,2-b]pyridin-6-yl)cyclohex-3-en-1-yl]-1,3-oxazolidin-2-one;tris((4S)-5,5-dimethyl-4-phenyl-3-[4-(1-pyrimidin-2-ylpyrrolo[3,2-b]pyridin-6-yl)cyclohexyl]-1,3-oxazolidin-2-one);hydride;oxido formate;bis(1-pyrimidin-2-yl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrrolo[3,2-b]pyridine).
Molecular Properties
| Compound Name | Dipotassium;6-bromo-1-pyrimidin-2-ylpyrrolo[3,2-b]pyridine;6-bromo-1H-pyrrolo[3,2-b]pyridine;2-chloropyrimidine;[(4R)-4-[(4S)-5,5-dimethyl-2-oxo-4-phenyl-1,3-oxazolidin-3-yl]cyclohexen-1-yl] trifluoromethanesulfonate;(4S)-5,5-dimethyl-4-phenyl-3-[(1R)-4-(1-pyrimidin-2-ylpyrrolo[3,2-b]pyridin-6-yl)cyclohex-3-en-1-yl]-1,3-oxazolidin-2-one;tris((4S)-5,5-dimethyl-4-phenyl-3-[4-(1-pyrimidin-2-ylpyrrolo[3,2-b]pyridin-6-yl)cyclohexyl]-1,3-oxazolidin-2-one);hydride;oxido formate;bis(1-pyrimidin-2-yl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrrolo[3,2-b]pyridine) |
|---|---|
| PubChem CID | 162047905 |
| Molecular Formula | C187H189B2Br2ClF3K2N37O20S |
| Molecular Weight | 3658.95 g/mol |
| Exact Mass | 3654.21 |
| IUPAC Name | dipotassium;6-bromo-1-pyrimidin-2-ylpyrrolo[3,2-b]pyridine;6-bromo-1H-pyrrolo[3,2-b]pyridine;2-chloropyrimidine;[(4R)-4-[(4S)-5,5-dimethyl-2-oxo-4-phenyl-1,3-oxazolidin-3-yl]cyclohexen-1-yl] trifluoromethanesulfonate;(4S)-5,5-dimethyl-4-phenyl-3-[(1R)-4-(1-pyrimidin-2-ylpyrrolo[3,2-b]pyridin-6-yl)cyclohex-3-en-1-yl]-1,3-oxazolidin-2-one;tris((4S)-5,5-dimethyl-4-phenyl-3-[4-(1-pyrimidin-2-ylpyrrolo[3,2-b]pyridin-6-yl)cyclohexyl]-1,3-oxazolidin-2-one);hydride;oxido formate;bis(1-pyrimidin-2-yl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrrolo[3,2-b]pyridine) |
| SMILES | Brc1cnc2cc[nH]c2c1.Brc1cnc2ccn(-c3ncccn3)c2c1.CC1(C)OB(c2cnc3ccn(-c4ncccn4)c3c2)OC1(C)C.CC1(C)OB(c2cnc3ccn(-c4ncccn4)c3c2)OC1(C)C.CC1(C)OC(=O)N(C2CCC(c3cnc4ccn(-c5ncccn5)c4c3)CC2)[C@H]1c1ccccc1.CC1(C)OC(=O)N(C2CCC(c3cnc4ccn(-c5ncccn5)c4c3)CC2)[C@H]1c1ccccc1.CC1(C)OC(=O)N(C2CCC(c3cnc4ccn(-c5ncccn5)c4c3)CC2)[C@H]1c1ccccc1.CC1(C)OC(=O)N([C@H]2CC=C(OS(=O)(=O)C(F)(F)F)CC2)[C@H]1c1ccccc1.CC1(C)OC(=O)N([C@H]2CC=C(c3cnc4ccn(-c5ncccn5)c4c3)CC2)[C@H]1c1ccccc1.Clc1ncccn1.O=CO[O-].[H-].[K+].[K+] |
| InChI | InChI=1S/3C28H29N5O2.C28H27N5O2.C18H20F3NO5S.2C17H19BN4O2.C11H7BrN4.C7H5BrN2.C4H3ClN2.CH2O3.2K.H/c4*1-28(2)25(20-7-4-3-5-8-20)33(27(34)35-28)22-11-9-19(10-12-22)21-17-24-23(31-18-21)13-16-32(24)26-29-14-6-15-30-26;1-17(2)15(12-6-4-3-5-7-12)22(16(23)26-17)13-8-10-14(11-9-13)27-28(24,25)18(19,20)21;2*1-16(2)17(3,4)24-18(23-16)12-10-14-13(21-11-12)6-9-22(14)15-19-7-5-8-20-15;12-8-6-10-9(15-7-8)2-5-16(10)11-13-3-1-4-14-11;8-5-3-7-6(10-4-5)1-2-9-7;5-4-6-2-1-3-7-4;2-1-4-3;;;/h3*3-8,13-19,22,25H,9-12H2,1-2H3;3-9,13-18,22,25H,10-12H2,1-2H3;3-7,10,13,15H,8-9,11H2,1-2H3;2*5-11H,1-4H3;1-7H;1-4,9H;1-3H;1,3H;;;/q;;;;;;;;;;;2*+1;-1/p-1/t3*19?,22?,25-;22-,25-;13-,15-;;;;;;;;;/m00000........./s1 |
| InChIKey | JDRVCCQTHKAOJF-POOIIJGVSA-M |
| XLogP | 30.24 |
| TPSA | 637.01 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 51 |
| Rotatable Bonds | 26 |
| Heavy Atoms | 255 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 3658.95 |
| LogP ≤ 5 | 30.24 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 51 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': '>_2_ester_groups', 'substructure': 'N/A'}, {'alert_name': 'aldehyde', 'substructure': 'N/A'}, {'alert_name': 'heavy_metal', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}, {'alert_name': 'peroxide', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 162047905 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.